OLUX-E^® Foam Efficacy - Atopic Dermatitis

OLUX-E^® Foam Effectively Clears Symptoms Overall With Proven Efficacy

Percent of Patients Clear or Almost Clear and Achieving Composite Endpoint of Treatment Success at Week 2^*2,3

* Data derived from a phase 3, double-blind, randomized studies (at Week 2). An Investigator's Static Global Assessment (ISGA) score of clear (0) or almost clear (1) was utilized, reflecting the traditional definition of treatment success; success rates were 59% vs 16% for Vehicle Foam in atopic dermatitis patients (P<0.0001). The composite endpoints measuring treatment success required multiple criteria; success rates were 52% vs 14% for Vehicle Foam in atopic dermatitis patients (P<0.0001).

OLUX-E^® Foam Effectively Treats Moderate to Severe Atopic Dermatitis.

Percent of Patients (n=251) Clear or Almost Clear of Atopic Dermatitis Symptoms at Week 2^*2

*Results from a phase 3, double-blind, randomized study, which measured proportion of patients using OLUX-E^® Foam vs Vehicle Foam who had a score of 0 or 1 for induration/papulation (56% vs 11%; P<0.0001), a score of 0 or 1 for erythema (53% vs 15%; P<0.0001), a score of 0 for pruritus (41% vs 8%; P<0.0001), and a score of 0 for lichenification (22% vs 4%; P <0.0001) at Week 2. Endpoints required a minimum 2-grade improvement.

Phase 3 Study

Find a Dermatologist

Enter Zip Code: